FDA药物库
目录号:L1300
3203种获得上市批准以及药典收录的原料药的独特集合,可用于高通量筛选和高内涵筛选 。
规格 |
---|
预溶于DMSO或水 |
100uL/well |
2x100uL/well |
询价获取超大折扣! |
您可以选择特定规格、位置的分子
定制您的化合物库
客户使用Selleck的FDA药物库发表文献631篇
- Protein Cell, 2021 1-12
- Nature, 2020 582(7811):289-293
- Cancer Cell, 2020 37(2):200-215.e5
- Cell Res, 2020 27;1-16.
- Cell Res, 2019 29(9):739-753
- Protein Cell, 2019 10(3):161-177
- Nat Med, 2017 23(4):405-408
- Physiol Rev, 2017 1;97(3):889-938.
- Cell Stem Cell, 2017 4;20(5):659-674.e9.
- Cell, 2020 181(7):1518-1532.e14
- Signal Transduct Target Ther, 2020 4;5:20.
- Cell Metab, 2019 7;29(5):1166-1181.e6.
- Cancer Discov, 2019 9(7):910-925
- Cancer Discov, 2018 8(4):498-515
- Nature, 2017 546(7659):533-538
- Cancer Discov, 2015 5(2):154-67.
- Nat Med, 2014 20(8):954-60
- Cancer Cell, 2021 S1535-6108(21)00383-4
- Chem Soc Rev, 2021 10.1039/d0cs01065k
- Cancer Discov, 2021 candisc.0872.2020
- Nat Methods, 2022 19(7):803-811
- Nat Biomed Eng, 2022 10.1038/s41551-022-00863-9
- Blood, 2022 blood.2022015414
- Cancer Discov, 2021 candisc.0930.2020
- Nat Immunol, 2024 25(10):1884-1899
- Nat Biomed Eng, 2024 10.1038/s41551-024-01273-9
- Comput Biol Chem, 2025 114:108290
- Nat Commun, 2024 15(1):4099
- Nat Commun, 2024 15(1):1537
- Theranostics, 2024 14(18):6947-6968
- Cancer Lett, 2024 588:216802
- Pharmacol Res, 2024 209:107420
- Elife, 2024 13RP93405
- Comput Biol Med, 2024 171:108163
- Biomed Pharmacother, 2024 174:116459
- J Infect Public Health, 2024 17(11):102561
- Int J Mol Sci, 2024 25(9)4675
- Int J Mol Sci, 2024 25(22)11881
- Int J Oncol, 2024 64(6)66
- World Allergy Organ J, 2024 17(12):101008
- Antimicrob Agents Chemother, 2024 e0034424.
- Biomedicines, 2024 10.3390/biomedicines12020286
- Biomedicines, 2024 12(2)286
- Molecules, 2024 29(6)1363
- ACS Omega, 2024 9(37):38820-38831
- PLoS One, 2024 19(1):e0295629
- Microbiol Spectr, 2024 e0175424.
- Sci Adv, 2024 10(50):eadq4274
- Antivir Ther, 2024 29(6):13596535241305536
- Cancer Res Commun, 2024 4(2):540-555
- bioRxiv, 2024 2024.10.06.616903
- Nat Commun, 2023 14(1):7576
- Nat Commun, 2023 14(1):6690
- Nat Commun, 2023 14(1):7574
- Acta Pharm Sin B, 2023 13(1):142-156
- Exp Mol Med, 2023 55(4):794-805
- J Exp Clin Cancer Res, 2023 42(1):249
- Adv Healthc Mater, 2023 e2300591.
- Int J Biol Sci, 2023 19(7):2270-2288
- Chem Sci, 2023 14(44):12747-12766
- mBio, 2023 e0137623.
- Cell Death Discov, 2023 9(1):57
- Front Pharmacol, 2023 14:1233253
- Front Pharmacol, 2023 14:1244317
- Int J Mol Sci, 2023 24(8)7578
- Int J Mol Sci, 2023 24(18)13863
- Int J Mol Sci, 2023 24(7)6038
- Int J Mol Sci, 2023 24(13)10696
- Pharmaceutics, 2023 15(3)925
- Am J Cancer Res, 2023 13(3):976-991
- Front Microbiol, 2023 14:1097413
- Cancers (Basel), 2023 15(7)2163
- Bioorg Chem, 2023 130:106264
- Virus Res, 2023 339:199248
- Chin Med, 2023 18(1):30
- J Biol Chem, 2023 299(12):105369
- J Biol Chem, 2023 299(3):102956
- ASN Neuro, 2023
- ERJ Open Res, 2023 9(1)00495-2022
- Eur J Pharm Sci, 2023 181:106362
- Sci Rep, 2023 13(1):14429
- Sci Rep, 2023 13(1):19588
- ACS Omega, 2023 8(37):34160-34170
- ACS Omega, 2023 8(11):10397-10402
- ACS Chem Biol, 2023 18(3):583-594
- Front Cardiovasc Med, 2023 10:1130635
- Chembiochem, 2023 e202300555.
- Sci Adv, 2023 10.1126/sciadv.adf0005
- Nat Prod Commun, 2023 18(1)
- Res Sq, 2023 rs.3.rs-2318750
- bioRxiv, 2023 10.1101/2023.04.03.535496
- bioRxiv, 2023 2023.07.12.548707
- Cancer Res Commun, 2023 3(7):1152-1165
- Res Sq, 2023 rs.3.rs-3246405
- Neuro Oncol, 2022 noac093
- J Med Virol, 2022 10.1002/jmv.27891
- Mol Psychiatry, 2022 27(1):490-501
- BMC Med, 2022 20(1):359
- J Cachexia Sarcopenia Muscle, 2022 13(6):3062-3077
- Cell Rep, 2022 39(2):110622
- Cell Rep, 2022 39(10):110913
- Mater Today Bio, 2022 17:100503
- Antiviral Res, 2022 209:105473
- Blood Adv, 2022 bloodadvances.2021006860
- Biomed Pharmacother, 2022 153:113432
- Drug Discov Today, 2022 S1359-6446(22)00170-2
- NPJ Regen Med, 2022 7(1):50
- Antioxidants (Basel), 2022 11(10)1855
- Cell Death Discov, 2022 8(1):82
- Cells, 2022 11(7)1162
- Biochem Pharmacol, 2022 204:115239
- iScience, 2022 25(10):105254
- Front Pharmacol, 2022 13:888308
- Front Pharmacol, 2022 13:837115
- Front Pharmacol, 2022 13:828643
- Front Pharmacol, 2022 13:977742
- Int J Mol Sci, 2022 23(20)12657
- Front Chem, 2022 10:876212
- Am J Cancer Res, 2022 12(4):1465-1483
- Am J Cancer Res, 2022 12(3):1102-1115
- Cancers (Basel), 2022 14(10)2527
- Cancers (Basel), 2022 14(17)4256
- Front Microbiol, 2022 13:1045291
- Cancers (Basel), 2022 14(8)1855
- Front Mol Biosci, 2022 9:837610
- Transl Oncol, 2022 16:101336
- Antibiotics (Basel), 2022 11(6)816
- Front Oncol, 2022 12:880552
- Viruses, 2022 14(7)1381
- Viruses, 2022 15(1)105
- Front Oncol, 2022 12:874168
- Molecules, 2022 27(8)2458
- Molecules, 2022 27(4)1283
- J Oncol, 2022 2022:4598573
- J Oncol, 2022 2022:5320421
- Immunol Lett, 2022 244:28-39
- Curr Med Chem, 2022 29(38):5925-5948
- Mult Scler Relat Disord, 2022 58:103499
- Biochimie, 2022 198:8-22
- Virology, 2022 577:1-15
- Microbiol Spectr, 2022 e0372622.
- Biochem Biophys Res Commun, 2022 632:181-188
- SLAS Discov, 2022 27(7):375-383
- SLAS Discov, 2022 S2472-5552(22)13673-7
- Res Microbiol, 2022 S0923-2508(22)00073-0
- Assay Drug Dev Technol, 2022 20(3):111-124
- CA Cancer J Clin, 2022 2(6):510-523.
- Methods Mol Biol, 2022 2452:379-391
- Cell Genom, 2022 2(2):100095
- Nat Commun, 2021 12(1):3907
- Mol Cell, 2021 S1097-2765(21)00995-3
- Biomaterials, 2021 271:120722
- Pharmacol Ther, 2021 228:107930
- Proc Natl Acad Sci U S A, 2021 118(28)e2026403118
- Mol Psychiatry, 2021 10.1038/s41380-021-01104-2
- Cancer Lett, 2021 520:132-142
- ACS Appl Mater Interfaces, 2021 13(22):25715-25726
- Int J Biol Macromol, 2021 S0141-8130(21)00897-7
- Elife, 2021 10e68714
- J Med Chem, 2021 64(23):17530-17539
- Front Immunol, 2021 12:649135
- Phytother Res, 2021 10.1002/ptr.7297
- Cell Death Discov, 2021 7(1):297
- Comput Struct Biotechnol J, 2021 19:4868-4883
- Int J Mol Sci, 2021 22(6)2915
- Front Pharmacol, 2021 12:685308
- Int J Mol Sci, 2021 22(9)4461
- Front Pharmacol, 2021 12:664176
- Front Pharmacol, 2021 12:695009
- Mol Cancer Res, 2021 molcanres.0301.2021
- Int J Oncol, 2021 59(1)42
- Mol Cancer Res, 2021 molcanres.0259.2021
- Antimicrob Agents Chemother, 2021 AAC.02577-20
- J Biomol Struct Dyn, 2021 1-22
- J Biomol Struct Dyn, 2021 1-17
- J Biomol Struct Dyn, 2021 1-25
- Hum Cell, 2021 10.1007/s13577-021-00612-1
- Hum Cell, 2021 34(3):1008-1018
- Hum Cell, 2021 10.1007/s13577-021-00643-8
- Future Med Chem, 2021 10.4155/fmc-2021-0025
- ACS Omega, 2021 6(36):23399-23411
- ACS Omega, 2021 6(22):14430-14441
- J Cancer, 2021 12(15):4616-4625
- Mol Divers, 2021 10.1007/s11030-021-10263-x
- Mol Inform, 2021 10.1002/minf.202000187
- Genes (Basel), 2021 12(2)300
- Hum Mol Genet, 2021 ddab207
- Biophys J, 2021 120(14):2848-2858
- Org Biomol Chem, 2021 19(26):5827-5835
- Biochem Biophys Res Commun, 2021 586:157-162
- ChemistryOpen, 2021 10(9):877-881
- Stem Cell Res, 2021 53:102207
- bioRxiv, 2021 2021.08.31.458413
- bioRxiv, 2021 2021.04.08.439071
- Nat Commun, 2020 11(1):2758
- Nat Commun, 2020 11(1):3606
- J Clin Invest, 2020 130(9):4969-4984
- EMBO J, 2020 39(14):e103812
- Redox Biol, 2020 36:101680
- Chemosphere, 2020 261:127756
- Vaccines (Basel), 2020 8(3)E401
- Antiviral Res, 2020 182:104884
- Antiviral Res, 2020 173:104650
- J Transl Med, 2020 18(1):257
- Eur J Med Chem, 2020 201:112559
- Eur J Med Chem, 2020 192:112175
- Life Sci, 2020 15;251:117627.
- Life Sci, 2020 259:118275
- Mol Cancer Ther, 2020 5;molcanther.1131.2019.
- Int J Mol Sci, 2020 27;21(7):2327.
- Front Pharmacol, 2020 11:590598
- Am J Cancer Res, 2020 10(2):507-522
- Am J Cancer Res, 2020 10(3):856-869
- Front Microbiol, 2020 21;10:2936.
- Cancers (Basel), 2020 12(6)E1418
- FASEB, 2020 doi:10.1096/fasebj.2020.34.s1.05778
- Viruses, 2020 12(10)E1067
- Sci Rep, 2020 15;10(1):684.
- Sci Rep, 2020 18;10(1):8159.
- Eur J Clin Microbiol Infect Dis, 2020 2 doi: 10.1007/s10096-020-03881-0
- J Biomol Struct Dyn, 2020 13;1-10.
- J Biomol Struct Dyn, 2020 38(10):3074-3086
- J Biomol Struct Dyn, 2020 1-13
- J Biomol Struct Dyn, 2020 1-8
- J Biomol Struct Dyn, 2020 1-12
- J Proteome Res, 2020 10.1021/acs.jproteome.0c00383
- Hum Cell, 2020 doi: 10.1007/s13577-020-00359-1
- Hum Cell, 2020 33(1):283-290.
- Hum Cell, 2020 doi: 10.1007/s13577-020-00365-3
- Hum Cell, 2020 33(2):427-436.
- Hum Cell, 2020 33(4):1311-1320
- Hum Cell, 2020 doi: 10.1007/s13577-020-00354-6
- Hum Cell, 2020 10.1007/s13577-020-00436-5
- J Clin Med, 2020 9(5)E1473
- BMC Cancer, 2020 20(1):590
- Orphanet J Rare Dis, 2020 15(1):170
- Mol Inform, 2020 10.1002/minf.202000115
- Mol Brain, 2020 13(1):124
- Acta Derm Venereol, 2020 12;100(5):adv00055.
- Genes (Basel), 2020 11(7)E722
- Hum Mol Genet, 2020 27;29(5):756-765.
- J Comput Aided Mol Des, 2020 34(7):731-746
- Invest New Drugs, 2020 10.1007/s10637-020-01011-3
- SLAS Discov, 2020 22;2472555220924478.
- Comput Biol Chem, 2020 88:107351
- Med Sci Monit, 2020 26:e927106
- Tissue Cell, 2020 66:101393
- Sci Adv, 2020 6(22):eaaz8201
- Sichuan Da Xue Xue Bao Yi Xue Ban, 2020 51(2):139-145.
- bioRxiv, 2020 2020.05.12.091082
- bioRxiv, 2020 doi:10.1101/2020.04.09.034421
- bioRxiv, 2020 2020.08.31.274639
- Nat Commun, 2019 10(1):1387
- Nat Commun, 2019 16;10(1):5715.
- Theranostics, 2019 9(21):6334-6353
- Cancer Lett, 2019 451:79-91
- Cell Rep, 2019 28(3):597-604
- Cell Chem Biol, 2019 16;26(5):699-710.e6.
- Mov Disord, 2019 34(3):323-334
- Cell Chem Biol, 2019 21;26(3):331-339.e3.
- Acta Pharmacol Sin, 2019 40(9):1245-1255.
- Oncogene, 2019 38(41):6737-6751
- Antiviral Res, 2019 161:1-9
- Antiviral Res, 2019 172:104637
- J Med Chem, 2019 62(21):9824-9836
- Biochem Pharmacol, 2019 168:224-236
- Mol Cancer Ther, 2019 18(9):1659-1668
- Front Pharmacol, 2019 10:912
- Am J Physiol Cell Physiol, 2019 1;317(4):C857-C866.
- Int J Oncol, 2019 55(5):1090-1096
- Virus Res, 2019 263:102-111
- Antimicrob Agents Chemother, 2019 10.1128/AAC.00994-19
- Front Oncol, 2019 9:1245
- Viruses, 2019 11(8)
- Sci Rep, 2019 9(1):19529
- Sci Rep, 2019 9(1):15812
- J Biomol Struct Dyn, 2019 37(12):3048-3057.
- Hum Cell, 2019 32(2):214-222.
- Hum Cell, 2019 32(2):202-213.
- Curr Med Chem, 2019 26(36):6614-6635.
- ACS Chem Biol, 2019 14(12):2887-2894
- RSC Adv, 2019 1696-1704
- Pathogens, 2019 8(3)
- Biochem Biophys Res Commun, 2019 515(1):92-98
- Med Mycol, 2019 10.1093/mmy/myz077
- Anticancer Res, 2019 39(11):5867-5877
- Sci Adv, 2019 5(5):eaav6528
- Comb Chem High Throughput Screen, 2019 22(7):483-495.
- Assay Drug Dev Technol, 2019 17(1):14-16
- Nat Commun, 2018 9(1):2546
- Nat Chem Biol, 2018 14(3):291-298
- Cancer Res, 2018 78(15):4370-4385
- EBioMedicine, 2018 37:344-355
- EBioMedicine, 2018 36:241-251
- Cell Rep, 2018 2;22(1):59-71.
- Antiviral Res, 2018 157:57-67
- Br J Pharmacol, 2018 175(2):168-180
- J Lipid Res, 2018 59(10):1916-1926
- mBio, 2018 3;9(4):e01034-18.
- Mol Cancer Ther, 2018 17(9):1984-1994.
- J Cell Physiol, 2018 233(1):422-433
- J Cell Physiol, 2018 233(5):3713-3722
- J Virol, 2018 92(16)
- Oncotarget, 2018 21;9(100):37429-37438.
- ACS Infect Dis, 2018 13;4(4):635-645.
- ACS Chem Neurosci, 2018 9(2):346-357
- Antimicrob Agents Chemother, 2018 63(1)
- Antimicrob Agents Chemother, 2018 62(1)
- mSphere, 2018 3(5)
- Sci Rep, 2018 30;8(1):11413.
- Sci Rep, 2018 6;8(1):13387.
- Eur J Clin Microbiol Infect Dis, 2018 37(1):141-148
- Mol Cell Endocrinol, 2018 460:229-237
- PLoS One, 2018 13(11):e0207872
- Pharm Res, 2018 36(2):27
- In Vitro Cell Dev Biol Anim, 2018 54(10):770-778.
- Protein Expr Purif, 2018 150:12-16
- Cell Death Dis, 2017 8(6):e2904
- Antiviral Res, 2017 146:76-85
- Drug Discov Today, 2017 22(2):199-203
- Int J Mol Sci, 2017 2;18(6):1185.
- J Virol, 2017 e01055-17
- Antimicrob Agents Chemother, 2017
- Sci Rep, 2017 5;7(1):4712.
- Sci Rep, 2017 7(1):525
- FEBS Lett, 2017 591(15):2311-2322.
- Chembiochem, 2017 4;18(13):1279-1285.
- Chem Biol Drug Des, 2017 90(4):629-636.
- Nat Commun, 2016 7:13297
- Nat Commun, 2016 11;7:13023.
- Clin Cancer Res, 2016 10.1158/1078-0432
- Proc Natl Acad Sci U S A, 2016 113(33):9339-44
- Cell Rep, 2016 14(6):1477-1487
- Antiviral Res, 2016 135:81-90
- Cell Death Discov, 2016 2:16041
- Antimicrob Agents Chemother, 2016 60(11):6532-6539
- Virol J, 2016 13;13:99.
- mSphere, 2016 14;1(5):e00194-16.
- Clin Exp Metastasis, 2016 33(4):385-99
- PLoS Negl Trop Dis, 2016 10(4):e0004584
- PLoS One, 2016 12;11(10):e0163615.
- Nat Commun, 2021 12(1):1117
- J Am Chem Soc, 2021 143(13):4979-4992
- Nat Chem Biol, 2021 10.1038/s41589-021-00751-4
- Clin Cancer Res, 2021 clincanres.4037.2020
- J Exp Clin Cancer Res, 2021 40(1):90
- Proc Natl Acad Sci U S A, 2021 118(13)e2009620118
- Cell Rep, 2021 35(1):108959
- Cell Rep, 2021 35(1):108940
- Am J Cancer Res, 2021 11(1):215-235
- J Biol Chem, 2021 jbc.RA120.016477
- Sci Adv, 2021 7(10)eabe7853
- Nat Commun, 2020 14;11(1):1792.
- Nucleic Acids Res, 2020 48(20):11566-11576
- J Allergy Clin Immunol, 2020 21;S0091-6749(20)30259-1.
- Cancer Res, 2020 15;80(4):832-842.
- EBioMedicine, 2020 60:102988
- Cancer Lett, 2020 469:195-206
- Cell Death Dis, 2020 2;11(3):158.
- Cell Death Dis, 2020 11(9):724
- Cell Rep, 2020 32(1):107845
- Cell Chem Biol, 2020 20;27(2):197-205.e6.
- Cell Chem Biol, 2020 16;27(1):94-104.e5.
- Stem Cell Reports, 2020 14(3):478-492
- Mol Ther Oncolytics, 2020 30;17:169-179.
- Int J Mol Sci, 2020 18;21(8):2825.
- Antimicrob Agents Chemother, 2020 4;AAC.02523-19.
- J Biol Chem, 2020 27;jbc.RA120.012981.
- Carcinogenesis, 2020 41(7):993-1004
- Sci Rep, 2020 24;10(1):5318.
- Toxicol Sci, 2020 1;174(2):218-240.
- Breast Cancer Res Treat, 2020 179(2):337-347.
- PLoS One, 2020 15(1):e0228189
- PLoS One, 2020 15(5):e0233089
- PLoS One, 2020 15(5):e0233672
- Sarcoma, 2020 2020:6312480
- bioRxiv, 2020 2020.04.20.051581
- ACS Pharmacol Transl Sci, 2020 3(6):1278-1292
- J Med Virol, 2019 91(8):1440-1447.
- Genome Biol, 2019 20(1):253
- Cancer Immunol Res, 2019 7(9):1523-1534
- Cell Rep, 2019 5;26(6):1544-1556.e8.
- Cell Chem Biol, 2019 21;26(2):235-243.e5.
- Acta Pharmacol Sin, 2019 10.1038/s41401-019-0246-4
- Neuropsychopharmacology, 2019 10.1038/s41386-018-0266-7
- Breast Cancer Res, 2019 21(1):37
- Drug Discov Today, 2019 24(2):390-402
- Anal Chem, 2019 91(8):4995-5003
- Cancer Gene Ther, 2019 10.1038/s41417-019-0127-5
- Cancers (Basel), 2019 30;11(2):156.
- Bioengineered, 2019 10(1):98-107
- Cell Signal, 2019 67:109508
- mSphere, 2019 4(3)e00047-19
- Molecules, 2019 24(20)E3798
- Stem Cells Int, 2019 2019:3435901
- Neurobiol Aging, 2019 76:24-34
- Biochem J, 2019 476(15):2209-2219
- Int J Parasitol Drugs Drug Resist, 2019 10:28-37.
- Breast Cancer Res Treat, 2019 10.1007/s10549-019-05504-5
- Virology, 2019 541:41-51
- Kaohsiung J Med Sci, 2019 10.1002/kjm2.12051
- Cancer Manag Res, 2019 11:8391-8405
- Sci Adv, 2019 5(6):eaav9784
- Curr Protoc Chem Biol, 2019 11(2):e64
- Nat Commun, 2018 9(1):1655
- Cancer Res, 2018 78(15):4344-4359
- Cancer Res, 2018 78(20):5731-5740
- EBioMedicine, 2018 28:80-89.
- Cell Rep, 2018 22(5):1185-1199
- Elife, 2018 7e35136
- Cancer Sci, 2018 109(4):1220-1229
- Oncotarget, 2018 9(57):31018-31031
- Oncotarget, 2018 9(40):26086-26095
- Oncotarget, 2018 9(32):22571-22585
- Antimicrob Agents Chemother, 2018 62(12)e01302-18
- Sci Rep, 2018 8(1):13106
- Sci Rep, 2018 21;8(1):14178.
- Sci Rep, 2018 8(1):12046
- PLoS Negl Trop Dis, 2018 12(3):e0006326
- Biochem Biophys Res Commun, 2018 495(1):1468-1475
- SLAS Discov, 2018 23(2):164-173
- Methods Mol Biol, 2018 1795:203-221.
- Methods Mol Biol, 2018 1765:333-347
- Nat Commun, 2017 17;8:16078.
- Proc Natl Acad Sci U S A, 2017 114(36):E7554-E7563
- Cell Rep, 2017 20(4):999-1015
- Anal Chem, 2017 89(12):6678-6685
- J Med Chem, 2017 60(7):2973-2982
- Lab Chip, 2017 31;17(3):511-520.
- Mol Cancer Ther, 2017 16(12):2656-2667
- Oncotarget, 2017 8(43):73745-73756
- Oncotarget, 2017 8(32):53154-53167
- Sci Rep, 2017 7(1):14416
- PLoS One, 2017 5;12(1):e0169407.
- Parasit Vectors, 2017 10(1):323
- SLAS Discov, 2017 22(5):507-515
- SLAS Discov, 2017 22(5):484-493
- SLAS Discov, 2017 22(9):1120-1130
- Parasitol Res, 2017 116(10):2619-2626.
- Biol Pharm Bull, 2017 40(8):1289-1298.
- Methods Cell Biol, 2017 138:651-679
- Pharmacol Res, 2016 113(Pt A):216-227
- J Invest Dermatol, 2016 136(10):2041-2048
- Database (Oxford), 2016 7;2016:baw041.
- Oncotarget, 2016 7(48):79637-79653
- J Cyst Fibros, 2016 15(3):285-94
- Biogerontology, 2016 17(5-6):907-920.
- PLoS Genet, 2016 12(9):e1006279
- Sensors (Basel), 2016 16(3)
- PLoS One, 2016 11(2):e0149848
- PLoS One, 2016 11(6):e0157497
- Cancer Biol Ther, 2016 3;17(5):546-57.
- Curr Protoc Toxicol, 2016 69:9.10.1-9.10.26
- Biosens Bioelectron, 2015 68:699-704
- Genome Biol, 2015 19;16(1):127.
- Clin Cancer Res, 2015 21(5):1172-82
- Cancer Res, 2015 75(24):5341-54
- Arch Pharm Res, 2015 38(9):1617-26.
- Mol Cancer Ther, 2015 14(5):1213-23
- Oncotarget, 2015 6(3):1531-43
- Oncotarget, 2015 6(34):35247-62
- Front Microbiol, 2015 8;6:676.
- Virulence, 2015 6(5):487-503
- Antimicrob Agents Chemother, 2015 60(2):862-72
- Antibiotics (Basel), 2015 9;4(4):424-34.
- Cell Cycle, 2015 14(1):109-22
- PLoS One, 2015 10(11):e0143033
- PLoS One, 2015 10(6):e0129234
- PLoS One, 2015 10(11):e0142655
- PLoS One, 2015 10(2):e0116688
- PLoS One, 2015 10(2):e0117246
- Biochem Biophys Res Commun, 2015 463(4):1122-8
- Pancreas, 2015 44(1):152-7
- Head Neck, 2015 37(12):1722-32
- Int J Mass Spectrom, 2015 377:719-717
- Assay Drug Dev Technol, 2015 13(8):456-65
- Nat Prod Rep, 2014 31(6):718-29
- Cancer Res, 2014 74:1702
- Oncotarget, 2014 30;5(18):8515-27.
- Oncotarget, 2014 5(15):6512-25
- Mol Cancer Res, 2014 12(5):703-13
- Antimicrob Agents Chemother, 2014 58(8):4875-84
- PLoS Negl Trop Dis, 2014 8(12):e3352
- PLoS One, 2014 9(6):e99440
- PLoS One, 2014 9(9):e106784
- Biochem Biophys Res Commun, 2014 452(3):315-21
- Assay Drug Dev Technol, 2014 12(9-10):514-26
- Curr Protoc Chem Biol, 2014 4:177-191
- Oncogenesis, 2013 2:e69
- Methods Enzymol, 2013 525:351-69
- Nat Commun, 2021 12(1):4360
- Nat Commun, 2021 12(1):5220
- Nat Commun, 2021 12(1):5111
- Cancer Commun (Lond), 2021 10.1002/cac2.12189
- Mol Cell, 2021 S1097-2765(21)00314-2
- Adv Sci (Weinh), 2021 8(11):e2003558
- Acta Pharm Sin B, 2021 11(1):181-202
- Clin Cancer Res, 2021 clincanres.5026.2020
- Clin Cancer Res, 2021 clincanres.0464.2021
- EMBO Mol Med, 2021 e14608
- PLoS Biol, 2021 19(5):e3001221
- Cancer Lett, 2021 514:12-29
- Brief Bioinform, 2021 bbab113
- Cell Death Dis, 2021 12(2):183
- Cell Rep, 2021 35(4):109024
- Cell Chem Biol, 2021 S2451-9456(21)00434-7
- EMBO Rep, 2021 e51781
- Stem Cell Res Ther, 2021 12(1):151
- J Med Chem, 2021 10.1021/acs.jmedchem.1c00367
- Eur J Med Chem, 2021 223:113576
- Hemasphere, 2021 5(7):e602
- Mol Oncol, 2021 10.1002/1878-0261.13083
- J Invest Dermatol, 2021 S0022-202X(21)01672-9
- Comput Struct Biotechnol J, 2021 19:3674-3681
- Commun Biol, 2021 4(1):573
- Clin Epigenetics, 2021 13(1):54
- Mol Cancer Ther, 2021 molcanther.MCT-20-0666-E.2020
- Mol Cancer Ther, 2021 molcanther.MCT-20-0377-A.2020
- Int J Mol Sci, 2021 22(4)1750
- Int J Mol Sci, 2021 22(15)8320
- Front Cell Dev Biol, 2021 9:673374
- ACS Infect Dis, 2021 10.1021/acsinfecdis.0c00853
- Cancers (Basel), 2021 13(3)576
- Transl Oncol, 2021 14(9):101147
- Transl Oncol, 2021 14(12):101230
- Transl Oncol, 2021 15(1):101260
- Methods, 2021 S1046-2023(21)00015-3
- Neoplasia, 2021 23(9):929-938
- Viruses, 2021 13(7)1255
- Front Oncol, 2021 11:735820
- Sci Rep, 2021 11(1):4390
- Sci Rep, 2021 11(1):14062
- Sci Rep, 2021 11(1):19343
- Sci Rep, 2021 11(1):19443
- AAPS J, 2021 23(2):35
- J Immunol, 2021 ji2000969
- Clin Transl Allergy, 2021 11(5):e12045
- J Biomol Struct Dyn, 2021 1-17
- Hum Cell, 2021 10.1007/s13577-021-00497-0
- Hum Cell, 2021 10.1007/s13577-021-00497-0
- Glycobiology, 2021 cwab048
- Hum Cell, 2021 10.1007/s13577-021-00579-z
- J Gastroenterol Hepatol, 2021 10.1111/jgh.15490
- Biochem J, 2021 BCJ20210257
- Biochem J, 2021 478(13):2481-2497
- Pathogens, 2021 10(2)253
- Epigenetics, 2021 1-12
- Cell Tissue Res, 2021 10.1007/s00441-021-03496-7
- Genes (Basel), 2021 12(5)742
- Cancer Cytopathol, 2021 10.1002/cncy.22448
- Biochem Biophys Res Commun, 2021 560:1-6
- J Biosci Bioeng, 2021 S1389-1723(21)00178-X
- FEBS Open Bio, 2021 11(5):1452-1464
- In Vivo, 2021 35(2):761-777
- Tohoku J Exp Med, 2021 254(1):17-23
- J Toxicol Sci, 2021 46(4):167-176
- Biol Pharm Bull, 2021 10.1248/bpb.b21-00531
- Genes Cancer, 2021 12:12-24
- STAR Protoc, 2021 2(1):100345
- FASEB Bioadv, 2021 3(5):334-355
- NAR Cancer, 2021 3(2):zcab018
- Vaccines (Basel), 2020 8(1)E72
- Antimicrob Agents Chemother, 2019 AAC.01470-19
- Biomed Opt Express, 2018 9(5):2214-2228
- Oncotarget, 2017 8(28):45088-45104
- Assay Drug Dev Technol, 2017 15(5):198-209
- ACS Infect Dis, 2016 2(3):180-186
- Proc Natl Acad Sci U S A, 2014 111(51):E5564-73
- Carcinogenesis, 2014 35(9):1968-76
- Mol Biol Cell, 2013 24(10):1559-73
- Anal Chem, 2023 95(20):7985-7992.
- Sci Transl Med, 2022 14(652):eabl5654
- Nat Commun, 2022 13(1):2169
- Nat Commun, 2022 13(1):2725
- Nat Commun, 2022 13(1):2572
- Adv Sci (Weinh), 2022 9(22):e2201785
- Nucleic Acids Res, 2022 50(13):7420-7435
- Cell Death Differ, 2022 10.1038/s41418-022-01064-2
- Clin Cancer Res, 2022 clincanres.0100.2022
- Clin Transl Med, 2022 12(7):e961
- Haematologica, 2022 107(1): 77–85
- BMC Med, 2022 20(1):175
- Oncogene, 2022 10.1038/s41388-022-02328-4
- Cells, 2022 11(7)1091
- Biosensors (Basel), 2022 12(2)96
- Front Cell Neurosci, 2022 16:852245
- ACS Chem Neurosci, 2022 13(10):1505-1516
- Neoplasia, 2022 27:100784
- Hum Cell, 2022 10.1007/s13577-022-00671-y
- Hum Cell, 2022 10.1007/s13577-022-00701-9
- Infect Drug Resist, 2022 15:295-306
- Exp Cell Res, 2022 413(2):113079
- J Neurophysiol, 2022 127(2):405-411
- Cold Spring Harb Protoc, 2022 10.1101/pdb.prot098269
- J Am Chem Soc, 2021 10.1021/jacs.1c06167
- Cell Death Differ, 2021 1-8
- Front Immunol, 2021 12:680611
- Eur J Med Chem, 2021 228:114022
- Cancer Sci, 2021 112(11):4641-4654
- Int J Mol Sci, 2021 22(22)12223
- Front Microbiol, 2021 12:651403
- Hum Cell, 2021 10.1007/s13577-021-00639-4
- Hum Cell, 2021 34(6):1911-1918
- Cannabis Cannabinoid Res, 2021 10.1089/can.2021.0132
- PLoS One, 2021 16(10):e0259129
- Mol Biol Rep, 2021 10.1007/s11033-021-06797-w
- J Virol, 2024 98(7):e0041323
- bioRxiv, 2024 2024.07.13.603377
- Nat Commun, 2023 14(1):3830
- J Infect Dis, 2023 228(5):591-603
- Cancers (Basel), 2023 15(5)1526
- Br J Cancer, 2022 126(12):1815-1823.
- J Med Virol, 2022 10.1002/jmv.27951
- J Exp Clin Cancer Res, 2022 41(1):86
- Cancer Metab, 2022 10(1):6
- Front Pharmacol, 2022 13:861295
- Endocrinology, 2022 163(8)bqac090
- J Mol Model, 2022 28(6):153
- J Exp Clin Cancer Res, 2023 42(1):100
- Biochem Biophys Res Commun, 2024 730:150393
- Elife, 2023 12RP84926
- Nat Commun, 2024 15(1):5379
- Int Immunopharmacol, 2024 141:112810
- Heliyon, 2024 10(13):e34033
- ACS Omega, 2021 6(38):24432-24443
- Exp Mol Med, 2024 10.1038/s12276-024-01298-9
- Sci Adv, 2024 10(37):eadp4408
- bioRxiv, 2024 2023.04.19.537364
- Mol Oncol, 2024 10.1002/1878-0261.13725
- Eur J Pharmacol, 2024 983:177000
- Proc Natl Acad Sci U S A, 2022 119(49):e2208458119
详细信息
配制 | 2828个化合物预溶于10mM DMSO,272个化合物预溶于10mM水,82个化合物预溶于2mM DMSO,19个化合物预溶于2mM水,2个化合物预溶于2mg/ml DMSO | ||
容器 | 铝箔热封的96深孔板 | ||
储存条件 (自收到货起) |
1年 | -20°C | 溶于DMSO |
2年 | -80°C | 溶于DMSO | |
发货 | 干冰或蓝冰物流 |
描述及优势
•3203种获得上市批准以及药典收录的的原料药的独特集合,可用于高通量筛选和高内涵筛选
•所有化合物均来自上市相关机构,如FDA,EMA,HMA,CFDA,PMDA,或者药典,如USP,BP,EP,JP,Ph.Int等
•提供FDA批准药物的新药申请(NDA)或仿制药申请(ANDA)信息
•帮助已有药物定位新的靶点
•通过临床实验,生物活性和安全性得到验证
•与肿瘤学、心脏病理学、抗炎反应、免疫学、神经医学、痛觉缺失等都有关
•结构多样,药效显著,可渗透细胞
•具有充分详细的结构说明及客户反馈资料
•NMR和HPLC技术保证产品高纯度
•以下是该分子库中上市分子的批准机构
Approved institution | Full name | Country |
FDA | U.S. Food and Drug Administration | United States of America |
CFDA | China Food and Drug Administration | China |
EMA | European Medicines Agency | European |
HMA | Heads Of Medicines Agency | European |
NDC | National Drug Code | United States of America |
PMDA | Pharmaceuticals and Medical Devices Agency | Japan |
DMF | Drug Master File | United States of America |